z-logo
open-access-imgOpen Access
Chromomycin A 3 binds to left‐handed poly(dG‐m 5 dC)
Author(s) -
SHAFER Richard H.,
ROQUES Bernard P.,
LePECQ JeanBernard,
DELEPIERRE Muriel
Publication year - 1988
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1111/j.1432-1033.1988.tb14009.x
Subject(s) - chromomycin a3 , polynucleotide , circular dichroism , absorbance , chemistry , crystallography , dna , stereochemistry , z dna , biochemistry , chromatography , heterochromatin , chromatin
The interaction of chromomycin A 3 (an antitumor antibiotic) with right‐handed and left‐handed polynucleotides has been studied by absorbance, fluorescence, circular dichroism, 31 P‐NMR and 1 H‐NMR techniques. Binding to either the B form of poly(dG‐dC) or the Z form of poly(dG‐m 5 dC) shifts the absorbance maximum to higher wavelength and enhances the fluorescence of the drug. Circular dichroic spectra of solutions containing various concentrations of chromomycin A 3 and fixed concentrations of either B or Z polynucleotides show well defined isoelliptic points at similar wavelengths. At the isoelliptic point, the drug complex with B DNA exhibits positive ellipticity while with ZDNA it exhibits negative ellipticity. 31 P‐NMR spectra of the chromomycin A 3 complex with the Z form of poly(dG‐m 5 dC) demonstrate that the Z conformation is retained in the drug complex up to one molecule drug/four base pairs. At Mg 2+ concentrations lower than that necessary to stabilize the left‐handed conformation of poly(dG‐m 5 dC) alone, 31 P analysis shows that chromomycin A 3 can bind simultaneously to both the B and Z conformations of poly(dG‐m 5 dC), with no effect on the B–Z equilibrium. These data demonstrate that chromomycin A 3 binds to left‐handed poly(dG‐m 5 dC) with retention of the left‐handed conformation up to saturating drug concentrations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here